Clinical Trials Are Crucial to Advance MPN Treatment

For lesser-known hematologic malignancies, such as myeloproliferative neoplasms, it is vital that ongoing clinical trials continue to investigate the tolerability and efficacy of novel regimens for the field to continue moving forward. 


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.